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Abstract  Brazilian  agricultural  biotechnology  has  seen  great  advances  in  recent  decades,  espe-
cially in  the  development  of  GM  crops,  including  soybean,  cotton,  and  maize,  which  has  placed
Brazil in  second  place  since  2013  in  the  ranking  of  countries  with  the  greatest  GM-cultivated
area. However,  patenting  these  technologies  is  somewhat  more  restrictive  in  Brazil  than  in
other countries,  such  as  the  USA  and  Japan,  especially  concerning  isolated  biological  material
from nature.  Hence,  the  intellectual  protection  of  crops  in  Brazil  is  encompassed  by  sui  generis
rights and/or  the  patenting  of  only  the  development  process.  Given  the  current  scenario  and  the
importance  of  biotechnology  for  the  Brazilian  agriculture  sector,  it  is  necessary  to  deeply  study
the patent  system  for  recently  developed  technologies  to  identify  opportunities  for  enterprises
and national  institutes  to  act  in  this  area.  The  application  of  novel  biotechnological  strate-
gies to  agriculture  will  contribute  to  the  expanding  agriculture  sector  and  become  part  of  the
solution to  global  challenges.  Through  this  study,  we  can  identify  the  major  companies  devel-
oping and  protecting  their  agrobiotechnologies.  Additionally,  a  more  detailed  analysis  veriﬁes
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tered regularly interspaced short palindromic repeats-associated protein-9 nuclease; CTNBio, National Biosafety Technical Commission;
CTP, chloroplast transit peptides; DII, Derwent Innovation Index; DNA, deoxyribunucleic acid; EMBRAPA, Brazilian Agricultural Research Cor-
poration; EMBRAPII, Brazilian Agency for Industrial Research and Innovation; FAO, Food and Agriculture Organization of the United Nations;
FAPESP, São Paulo Research Foundation; GM, genetically modiﬁed; INPI, National Institute of Industrial Property; IPC, International Patent
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that  although  there  are  some  restrictions  in  Brazilian  laws,  GM  patent  applicants  ﬁnd  ways  to
obtain intellectual  protection  for  the  tools  they  use  in  the  development  of  GM  crops,  which
include regulatory  sequences,  gene  constructs  and  production  methodologies.  Mechanisms  to
stimulate  investment  in  Brazilian  research  companies  and  public  policies  must  be  consolidated,
allowing investment  and  public--private  partnerships  in  this  sector,  with  the  aim  of  applying
biotechnological  knowledge  and  turn  it  into  products  demanded  by  society.
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in  Brazil,  we  ﬁrst  reported  the  main  transgenic  eventsntroduction
ccording  to  data  from  FAO  (United  Nations,  2017),  in  2050,
he  world  population  will  be  29%  greater  than  today,  and  70%
ill  be  urban.  The  increasing  demand  for  food  in  emerging
ountries,  the  volatility  of  food  prices,  climate  change,  soil
egradation  and  water  shortages  will  be  among  the  major
hallenges  to  ﬁghting  hunger,  which  affects  795  million  peo-
le  worldwide,  including  780  million  in  developing  regions
FAO,  2015).  These  issues  conﬁrm  the  importance  of  invest-
ng  in  technological  alternatives  in  the  agriculture  sector
hat  can  be  tailored  to  local  conditions,  aiming  to  increase
he  amount  of  food  and  to  exploit  conditions  to  promote
nclusive  growth  (FAO,  2015).
One  of  these  alternatives  continues  to  be  the  produc-
ion  of  GM  plants  with  traits  that  confer  higher  productivity
nd  better  alimentary  and  crop  conditions  allied  with  suit-
ble  soil  exploitation.  The  ﬁrst  GM  crop  developed  was
 tobacco  (Nicotiana  tabacum)  variety  produced  by  Mon-
anto  scientists  35  years  ago  that  conferred  resistance  to
minoglycoside  antibiotics  (Fraley  et  al.,  1983).  Recently,
MBRAPA  developed  a  common  bean  variety  (event  5.1)
esistant  to  BGMV,  which  shows  the  impact  of  this  tech-
ology  in  Brazil.  Despite  the  importance  of  virus-resistant
M  plants,  most  transgenic-growing  ﬁelds  also  develop
erbicide-tolerant  and  insect-resistant  plants.  In  this  way,
ifferent  strategies  have  been  employed  to  genetically  mod-
fy  plants  and  obtain  varieties  that  are  resistant  to  insect
ests,  most  often  by  transforming  the  hosts’  genes  for  pro-
ein  expression  that  interferes  in  the  life  cycle  of  insects
r  that  is  lethal  to  them,  such  as  enzyme  inhibitors  and
ectin  genes.  Cry  toxins  from  Bacillus  thuringiensis  have
lso  been  expressed  in  transgenic  cultures  and  substantially
ontributed  to  the  efﬁcient  control  of  insect  pests,  dra-
atically  reducing  the  use  of  chemical  pesticides  (Bravoa,
ikitvivatanavong,  Gill,  &  Soberon,  2011).
According  to  the  ISAAA,  from  1996  to  2016,  there  was
n  accumulation  of  2  billion  hectares  dedicated  to  GM
rop  production  for  the  market  (ISAAA,  2016).  The  main
M-growing  countries  in  2016  were  the  USA  (72.9  million
ectares),  Brazil  (49.1  million  hectares),  Argentina  (23.8
illion  hectares),  Canada  (11.6  million  hectares)  and  India
10.8  million  hectares)  (ISAAA,  2016).  In  Brazil,  there  was  an
ncrease  of  11%  in  the  area  used  for  transgenic  crop  cultiva-
ion  from  2015  to  2016,  of  which  soybean,  maize  and  cotton
epresent  the  majority  of  crops,  corresponding  to  93.4%  of
he  total  area  growing  GM  plants  (ISAAA,  2016).  ISAAA  also
emonstrated  in  2016  that,  for  soybeans,  growers  obtained
dhesion  of  96.5%  for  GM  varieties.  For  maize  and  cotton,
dhesion  was  88.5%  and  79%,  respectively.  Regarding  the
rea  increase  relative  to  each  crop,  from  2015  to  2016,  soy-
ean,  maize  and  cotton  saw  7.5%,  16.1%  and  6.3%  increases,
a
N
2espectively  (ISAAA,  2016).  Hence,  the  adhesion  of  GM  tech-
ology  and  the  cultivation  area  increased  simultaneously.
his,  however,  should  be  prevented  because  there  is  a  limit
o  the  area  available  for  cultivation,  focusing  on  environ-
ental  preservation.
To couple  the  adhesion  to  GM  crops  to  economic  devel-
pment,  there  are  2  intellectual  protection  mechanisms
sed  in  Brazil:  the  patent  system  (Brasil,  1996) and  the  sui
eneris  rights  of  cultivars  (Brasil,  1997).  Once  protected  and
eleased  to  the  market,  these  plants  ensure  considerable
roﬁts  for  their  technology  owners  though  the  payment  of
oyalties.
Regarding  the  ﬁrst  mechanism,  the  Law  of  Industrial
roperty  (N.  9279  from  May  14th  1996)  speciﬁes  that  ‘‘the
hole  or  a  part  of  natural  living  beings  and  biological  mate-
ials,  even  when  their  genome  or  germplasm  are  isolated,
s  well  as  natural  biological  processes’’  are  not  considered
nventions.  It  is  important  to  remark  that  GM  plants  and
M  animals  are  considered  inventions  in  Brazil,  but  they
ren’t  patentable  according  Article  18  (III  according  the  Law
.  9279/96).  The  only  living  beings  that  can  be  considered
atentable  inventions  under  Brazilian  law  are  transgenic
icroorganisms,  which  can  be  patented  if  they  meet  the
wo  conditions  of  patentability  (clarity  and  descriptive  suf-
ciency)  and  the  3  patentability  requirements  (novelty,
nventive  step  and  industrial  application).
In  addition,  processes  involving  living  organisms  (e.g.,
ethods  for  the  development  of  transgenic  plants),  gene
onstructs  (e.g.,  expression  vectors  and  cassettes),  recom-
inant  proteins  and  compositions  of  biological  extracts  are
lso  patentable  according  to  the  Brazilian  law.  This  means
hat  in  the  case  of  GM  plants,  the  tools  and  methods  for  their
evelopment  can  be  protected,  but  not  the  plants  them-
elves.  In  this  case,  it  is  possible  to  resort  to  the  second
echanism,  known  as  crop  protection,  based  on  sui  generis
ights  and  ruled  by  Law  N.  9456/97  (Brasil,  1997),  which
rants  owners  crop  protection  for  15  years,  except  for  vines,
ruit  trees,  forest  species  and  ornamental  plants,  whose
rotection  period  is  18  years.  Accordingly,  considering  the
mpact  of  GM  plants  on  the  Brazilian  agriculture  sector  in
he  worldwide  context,  in  this  work,  we  provide  an  outlook
n  intellectual  property  in  agricultural  biotechnology  from
010  to  2016.
ethods
o  analyse  the  situation  for  patented  agrobiotechnologiespproved  by  CTNBio  based  on  scientiﬁc  papers  and  reports.
ext,  we  searched  the  database  and  reports  of  MAPA,  in
017,  for  protected  and  registered  crops.  We  also  performed
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an  analysis  of  patent  requests  (biotechnology  area)  from
2000  to  2015  in  the  WIPO  database  (WIPO,  2017a) based
on  the  following  IPC  codes  (WIPO,  2017b):  C07G,  C07K,
C12M,  C12P,  C12Q,  C12R  and  C12S.  In  this  case,  two  search
strategies  were  performed:  (a)  patents  applied  in  Brazil  and
(b)  patents  of  Brazilian  origin.  A  comparative  analysis  was
also  performed  analysing  different  countries.  In  this  way,
we  used  strategy  ‘‘(b)’’  selecting  the  options  for  ‘‘Ofﬁce’’
as  Brazil/USA/India/Argentina/China/Canada.  Finally,  we
analysed  the  patent  protection  system  for  agrobiotechnolo-
gies  in  the  Derwent  Innovation  Index  (DII)  database  using
search  strategy  based  on  the  International  Patent  Classiﬁca-
tion  (IPC).
Aiming  to  provide  an  overview  of  patent  applications  in
agricultural  biotechnology  in  Brazil,  we  created  a  search
strategy  based  on  the  IPC  used  by  the  OECD  from  2010  to
2016,  focused  on  the  agriculture  sector  and  restricted  to
Brazilian  documents.  Hence,  the  query  sentence  used  was  as
follows:  IP=(A01H-001/00  OR  A01H-004/00  OR  A61K-038/00
OR  A61K-039/00  OR  A61K-048/00  OR  C02F-003/34  OR  C07G-
011/00  OR  C07G-013/00  OR  C07G-015/00  OR  C07K-004/00
OR  C07K-014/00  OR  C07K-016/00  OR  C07K-017/00  OR  C07K-
019/00  OR  C12M*  OR  C12N*  OR  C12Q*  OR  C12S*  OR  C12P*
OR  G01N-027/327  OR  G01N-033/53  OR  G01N-033/54  OR
G01N-033/55  OR  G01N-033/57  OR  G01N-033/68  OR  G01N-
033/74  OR  G01N-033/76  OR  G01N-033/78  OR  G01N-033/88
OR  G01N-033/92)  AND  PN=BR*.  Data  retrieved  from  DII  were
analysed  using  Vantage  Point  software  (Georgia  Tech/Search
Technology  Inc.,  Atlanta,  USA).
Results and  discussion
Approved  GM  plants  for  the  Brazilian  market
Following  the  approval  of  the  Law  of  Crop  Protection  in
Brazil  (N.  9456/97),  the  ﬁrst  GM  crop  event  was  released  in
the  Brazilian  market  in  1998  --  the  soybean  variety  Roundup
Ready  containing  the  cp4epsps  gene  that  conferred  toler-
ance  to  glyphosate  (Brasil,  1998).  Thus,  it  became  critical
to  elucidate  the  complex  intellectual  property  context  for
glyphosate-tolerant  soybean  cultivars  and  protection  strate-
gies  in  agricultural  biotechnology  to  promote  the  legal  safety
of  those  involved  in  these  technologies,  since  for  the  farm-
ers  it  is  hard  to  correlate  sometimes  the  royalties  payment
with  the  intellectual  property  enterprises  right  (Rodrigues,
Lage,  &  Vasconcellos,  2011).  The  Law  of  Biosafety  (N.  11105)
was  thus  created  in  2005  (Brasil,  2005a)  and  provided  safety
rules  and  surveillance  mechanisms  for  activities  involving
GM  organisms  and  their  derivatives;  it  also  instituted  the
CNBS  and  restructured  CTNBio.
In  2005,  the  ﬁrst  commercial  GM  cotton  (Bolgard  I --
Monsanto)  was  also  approved,  containing  the  cry1ac  gene
that  conferred  insect  resistance  (Brasil,  2005b).  In  2007,
Monsanto,  Bayer  and  Syngenta  companies  developed  and
received  approval  for  their  ﬁrst  commercial  transgenic
maize  events  in  Brazil:  MON810  (containing  the  cry1ab  gene
for  insect  resistance),  Libert  Link  (containing  the  pat  gene
for  herbicide  tolerance)  and  TL  (containing  both  cry1ab  and
pat  genes),  respectively.  Following  this,  many  other  GM
events  were  released  to  the  Brazilian  market,  suggesting
that  the  referred  laws  were  deﬁnitive  in  paving  the  way
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or  these  processes.  In  addition,  the  transgenic  common
ean  event  5.1  from  EMBRAPA  and  the  higher-productivity
ucalyptus  from  FuturaGene  were  also  approved  by  CTNBio
Brasil,  2011,  2018a).
In  2016,  CTNBio  approved  18  GM  organisms  for  the
arket,  of  which  9  were  GM  plants.  According  to  the
ommission,  there  are  currently  66  transgenic  plant  events
ommercially  approved  in  Brazil,  of  which  40  are  maize
vents,  13  cotton  events,  11  soybean  events,  1  common
ean  event  and  1  eucalyptus  event  (CTNBio,  2016;  2017).
TNBio  reports  (CTNBio,  2016;  2017) show  increasing  inter-
st  from  multinational  companies  in  the  development  of
M  plants  characterised  by  insect  resistance  and  herbicide
olerance,  especially  using  gene  pyramiding.
Despite  a  growing  number  of  Brazilian  published  patents
n  the  general  area  of  biotechnology  since  the  Law  of  Indus-
rial  Property  (1996),  we  notice  that  Brazil  is  far  behind  the
SA  and  China  (Table  1),  which  reveals  an  urgent  need  to
nvest  much  more  in  innovation,  including  patent  protec-
ion,  to  help  Brazil  be  more  competitive  in  the  biotechnology
ector.
razilian  protected  GM  crops
ccording  to  internal  reports  from  MAPA  and  an  analysis  of
ts  protected  crop  database  (MAPA,  2017)  there  were  2318
rotected  crops  in  Brazil,  of  which  628  had  a  deﬁnitive  pro-
ection  certiﬁcation:  593  soybean  crops,  34  cotton  crops  and
 common  bean  crop  (BRS  FC401  RMD  from  EMBRAPA).  By
une  2017,  there  were  2214  GM  crops  registered  in  MAPA,
hich  means  they  are  ruled  for  commercial  purposes.  Of
hese  crops,  51%  represent  soybean,  45%  maize,  3.7%  cotton,
.15%  common  bean  and  0.15%  eucalyptus.
Data  from  Fig.  1  show  the  tendency  towards  an  increase
n  the  number  of  registered  GM  crops  in  Brazil  --  especially
oybean  --  and  highlight  the  impact  of  this  technology  on
razilian  agribusiness.  The  decrease  shown  in  Fig.  1 for  the
ore  recent  years  is  probably  due  to  a  delay  in  indexing
ata.  In  the  case  of  maize,  although  there  are  a  reasonable
umber  of  GM  crops,  owners  usually  prefer  to  protect  their
echnology  through  secret  industrial  systems  because  this
pecies  provides  hybrid  crops.
gricultural  Biotechnology:  analysis  of Brazilian
atent protection
ECD  data  for  2015  identiﬁes  the  USA,  EU  members  and
apan  as  the  main  countries  with  patent  applications  in  the
iotechnology  area  for  the  period  from  2010  to  2013  (OECD,
015).
An  analysis  of  published  patents  in  the  biotechnology
rea  in  Brazil  (Fig.  2) shows  that  despite  the  large  num-
er  of  patent  applications,  most  of  the  patenting  effort  is  of
oreign  origin,  which  are  simply  represented  by  ‘‘Brazilian
ocuments’’,  in  contrast  to  ‘‘documents  of  Brazilian  ori-
in’’,  since  Brazilian  documents  include  patents  of  foreign
rigin  but  applied  in  Brazil,  whereas  documents  of  Brazilian
rigin  refer  to  patents  that  have  ﬁrst  application  in  Brazil
nd  are  usually  done  by  Brazilian.  This  demonstrates  the
nterest  of  several  international  actors  in  protecting  their
nventions  in  the  Brazilian  market  and  indicates  that  given
72
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Table  1  Number  of  patent  documents  in  biotechnology  for  the  main  GM  plant-producing  countries  (2000--2015).
Country  2000  2001  2002  2003  2004  2005  2006  2007  2008  2009  2010  2011  2012  2013  2014  2015
Argentina  6  6  16  20  24  18  20  25  22  18  16  26  19  21  36  18
Brazil 30  42  72  49  87  70  79  75  107  128  110  114  97  155  165  168
Canada 727  777  1019  1065  1047  916  711  709  692  736  703  748  644  629  706  453
China 424  2563  2169  1291  1508  2266  2433  2746  3835  4511  5573  7211  8840  10,091  11,695  6374
India 48  65  103  172  185  203  224  317  298  231  249  276  298  252  271  318
United States  of  America  11,011  13,134  17,486  18,578  15,894  15,308  13,350  13,564  13,845  13,929  13,732  14,598  14,190  14,957  17,139  12,905
Source:  Created by the authors based on WIPO data (WIPO, 2017a).
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Figure  1  Evolution  of  the  number  of  GM  crops  registered  in  MAPA.
Source:  Created  by  the  authors  based  on  MAPA  data  (WIPO,  2017a).
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the  important  knowledge  base  built  over  the  years  in  the
ﬁeld  of  biotechnology  in  Brazil,  national  inventors  could
demonstrate  more  signiﬁcant  participation  in  patenting  in
this  technological  ﬁeld.
A  study  performed  by  INPI  concerning  applied  biotech-
nology  patents  in  Brazil  by  Brazilian  owners  from  2009  to
2013  concluded  that  most  of  the  applications  were  from
companies  and  universities  and  were  related  to  the  agroin-
dustrial  sector,  especially  those  involving  GM  plants  (Verde,
Dos  Santos,  &  Guerrante,  2015).  INPI  also  showed  UNICAMP
as  the  ranking’s  leading  applicant,  with  USP  and  EMBRAPA
also  being  important.
Using  the  above-mentioned  strategy  to  analyse  Brazil-
ian  documents  representing  patent  applications  in  the
biotechnology  sector  from  2010  to  2016,  3711  results  were
retrieved,  of  which  916  were  retained  after  reﬁning  the
search  to  agricultural  biotechnology.  Of  these,  47%  were
related  to  plants,  32%  to  animals  and  15%  to  microorganisms.
Those  related  to  microorganisms  mostly  involve  biofuel  pro-
duction  processes  using  algae  but  also  involve  molecule
biosynthesis,  cultivation  methods,  fermentation  processes,
vaccines  and  cosmetics  composition,  probiotics  and  com-
positions  for  the  biological  control  of  plant  pests.  Those
p
t
U
iotechnology  from  2000  to  2015  in  Brazil.
ocuments  for  animals  mostly  involve  vaccines  and  methods
or  treating  human  and  animal  diseases  but  also  involve  GM
nimals,  diets,  disease  detection  methods,  synthetic  genes
or  veterinary  applications,  methods  for  animal  reproduc-
ion  (e.g.,  artiﬁcial  ovaries,  sperm  enrichment),  genotyping
hips,  molecular  markers,  cryopreservation,  among  others.
n  the  case  of  plants,  most  (approximately  93%)  involve
he  development  of  GM  plants  but  also  involve  culture
edia,  bioreactors,  gene  mapping,  seed  analysis,  fertilizers,
mbryo  analysis,  hybrid  production,  molecular  markers,  and
rafting.
An  analysis  of  priority  countries  revealed  that  most  of
he  Brazilian  patent  documents  from  2010  to  2016  were
rst  applied  in  Canada  (523),  the  USA  (511)  and  South  Korea
260),  which  strongly  suggests  that  these  countries  are
he  main  research  development  sites  resulting  in  patent
pplications  in  Brazil.  Brazil  was  the  fourth  in  this  ranking
203).  The  results  showed  that  Australia,  China,  Japan  and
he  Philippines  are  also  interested  in  the  Brazilian  market,
ossibly  due  to  the  extensive  area  used  for  agriculture  in
he  country  and  to  well-established  GM  cultivation.  The
SA,  EU  countries  and  China  are  other  targets  of  market
nterest  because  the  USA  and  China  are  worldwide  leaders
74  L.  Figueiredo  et  al.
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very  slow  rate  of  patent  analysis  in  Brazil.  When  focusing  on
requested  patents  for  GM  plants  in  the  same  period  (Fig.  5),
it  was  found  that  they  follow  almost  exactly  the  same  pat-
tern  as  that  for  agrotechnologies  in  general  (Fig.  4).
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Figure  3  Ranking  (Top  10  --  legal  persons)  of  the  main  
n  most  technologies,  and  EU  countries  have  powerful
iotechnology  research  centres.
Examining  the  major  patent  applicants  in  Brazil,  Dow
groSciences,  BASF  and  DuPont  Pioneer  were  the  main
atent  owners  in  agrobiotechnologies,  and  in  the  national
ontext,  EMBRAPA  was  the  main  applicant,  with  17  published
atent  documents,  representing  6th  place  in  the  ranking,
ollowed  by  the  Danish  company  NOVOZYMES  (Fig.  3).
We  must  also  emphasise  the  acquisition  of  companies
ver  the  years.  In  2017,  for  instance,  Dow  AgroSciences  was
erged  with  DuPont  Pioneer  (Globo,  2017),  Monsanto  was
ought  by  Bayer  (Valor  Econômico,  2017a)  and  Syngenta  was
old  to  ChemChina  (Valor  Econômico,  2017b).  These  three
arge  companies  established  in  the  agriculture  sector  con-
rol  more  than  60%  of  the  worldwide  seed  and  agrochemical
arkets  (Valour  Econômico,  2017c).
Considering  the  30  main  applicants  in  agricultural
iotechnology,  EMBRAPA  stands  out  as  the  most  linked  with
ifferent  institutions  through  partnerships,  either  Brazilian
e.g.,  UnB,  FAPESP  and  UFRGS)  or  foreign  (e.g.,  with  BASF).
ASF  also  has  a  striking  link  with  natural  persons,  probably
ecause  individual  inventors  are  considered  owners  in  the
SA.  Abbott  and  Abbvie  were  also  found  to  be  linked,  likely
ecause  the  pharmaceutical  company  Abbott  spun  off  Abb-
ie.  Danisco  was  linked  to  DuPont  Pioneer  because  it  was
ncorporated  into  DuPont  in  2011  (Supplementary  Figure  1).
Kenneth  E.  Narva  from  Dow  AgroSciences  is  the  inventor
ho  ﬁgures  in  the  largest  number  of  patent  applications  of
his  study;  these  usually  involve  insect  (Cry  1F,  RPA70,  RPS6,
ry1Ab,  Cry2Aa,  Cry1C,  Cry1Da,  Cry1Be,  Cry1Fa,  Cry2Aa,
ry1I,  Cry1E,  Cry-1Da  and  Cry1  Ca  proteins)  and  nematode
Cry14,  Cry  5  and  Cry  6  proteins)  control.
Analysing  these  916  agricultural  biotechnology  patent
ocuments  according  to  the  IPC  (WIPO,  2013),  we  found
hat  most  of  them  were  classiﬁed  as  C12N  15/82  (vectors
r  expression  systems  especially  adapted  to  plant  cells)  or
01H  5/00  (angiosperms),  conﬁrming  results  indicating  that
atent  applications  mostly  involve  GM  plants.  This  shows
espite  the  restrictions  in  industrial  property  legislation
egarding  the  protection  of  plants  by  the  patent  system,
any  companies  and  institutions  are  interested  in  protecting
elated  biotechnological  tools  necessary  for  the  develop-
ent  of  GM  plants  in  Brazil.
F
iigure  4  Evolution  of  Brazilian  patent  requests  per  year  in
gricultural  Biotechnology  (2010--2016).
Analysing  the  evolution  of  patent  applications  in  Brazil  in
he  ﬁeld  of  agricultural  biotechnology  (Fig.  4),  a  progressive
ecline  was  shown,  with  some  interfering  factors:  patents
till  under  the  secrecy  period;  a  delay  in  database  updates;
r  disinterest  in  searching  for  protection  because  of,  among
ther  factors,  (1)  the  restrictive  scope  of  patent  protec-
ion  from  Brazilian  law  in  the  biotechnology  ﬁeld  or  (2)  theYear of application
igure  5  Evolution  of  Brazilian  patent  requests  per  year
nvolving  GM  plants  (2010--2016).
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Patenting  process  for  GM  crops  in  Brazil
Despite  restrictions  in  the  laws  concerning  the  patent  pro-
tection  of  plants,  interest  clearly  remains  in  protecting
biotechnological  tools  useful  for  the  development  of  GM
crops  in  Brazil,  as  318  out  of  the  916  reﬁned  documents  (35%)
comprised  the  development  of  GM  crops.  A  more  detailed
analysis  places  Brazil  in  the  5th  place  of  applicant  countries,
with  the  USA,  Canada  and  South  Korea  being  the  main  appli-
cants,  indicating  other  countries’  growing  interest  in  the
Brazilian  market.
Regarding  the  type  of  protected  GM  crops,  most  are
related  to  genes  or  proteins  protecting  against  insecti-
cidal  activity  (especially  against  Lepidoptera,  Coleoptera
and  Hemiptera)  and  providing  tolerance  to  herbicides  (e.g.,
2,4-D  and  glyphosate).  In  the  ﬁrst  case,  the  most  cited  tar-
get  insect-pest  species  are  Ostrinia  nubialis  (Lepidoptera),
Spodoptera  frugiperda  (Lepidoptera),  Diabrotica  speciosa
(Coleoptera),  Pseudoplusia  includens  (Lepidoptera),  Anti-
carsia  gemmatalis  (Lepidoptera)  and  Euschistus  heros
(Hemiptera),  and  their  control  is  based  on  the  insertion  of
genes  coding  for  Cry  toxins.
Table  2 lists  patent  requests  from  the  main  owners
related  to  insect  resistance.  Although  requests  referring  to
Dabei  Nong  relate  to  Chinese  insect  pests,  these  patent
applications  in  Brazil  may  aim  to  protect  a  possibly  useful
technology  if  this  pest  spreads  to  Brazil.  This  table  also  indi-
cates  different  protection  strategies  used  by  owners:  gene
stacking  technologies,  transgenic  events  containing  stacked
genes  and  methods  for  developing  insect-resistant  GM  plants
(e.g.,  through  RNAi).
The  documentation  for  the  listed  patent  requests  also
describes  other  GM-related  technologies  such  as  plant
transformation  methods,  GM  organism  detection  kits,  site-
directed  integration  methods  such  as  gene  editing  tools
(e.g.,  ZFNs  and  TALENs),  function  restoring  genes  for  plant
male  sterility,  target  loci  detection  methods  for  foreign
DNA,  methods  of  introgression  for  transgenic  events,  plant
regulatory  sequences  (e.g.,  promoters),  devices  and  GM
microorganisms  used  in  plant  transformation,  GM  plants  with
oil  production  improvement,  CTPs,  RNAi  strategies,  fusion
proteins,  proteins  for  nematode  control  and  genes  for  yield
improvement  (e.g.,  increase  in  biomass  and/or  seed  pro-
ductivity).  Although  the  use  of  other  genome  engineering
technologies  such  as  CRISPR/Cas9  is  on  the  rise,  few  doc-
uments  based  on  these  were  found,  perhaps  because  they
were  developed  recently,  and  many  patent  documents  may
be  still  within  the  secrecy  period.
Analysing  the  patent  requests  related  to  GM  crops  made
it  possible  to  observe  that  owners  try  to  include  not  only
the  central  invention  (usually  a  gene  or  a  protein)  but
also  any  surrounding  technologies  with  possible  commer-
cial  importance,  such  as  the  GM  plant  itself  or  its  parts,
gene  constructs  or  cassettes,  transgenic-derived  products,
methods  involving  invented  molecules  and  even  ﬁelds  con-
taining  these  organisms.  Otherwise,  most  of  these  items  will
have  their  protection  denied  in  Brazil  by  the  law,  although
INPI  holds  that  protection  of  items  containing  natural  bio-
logical  products  must  not  be  considered  solely  dilutions  of
non-patentable  technologies  (INPI,  2015a).
It  was  also  observed  that  approximately  22%  of  the  iden-
tiﬁed  patent  applicants  have  a  ‘‘ﬁled’’  status  in  INPI  most
f
e
n
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f  the  time  due  to  the  lack  of  payment  of  annuities.  This
tatus  may  have  a  number  of  causes:  (1)  temporary  prob-
ems  in  the  INPI’s  processing  of  the  fees  paid  due  to  changes
n  their  value  and  the  need  for  proof  by  the  applicant,  (2)
ithdrawal  by  owners  or  (3)  management  trouble  for  active
atents.  The  last  cause  is  less  likely  because  owners  have  a
ong  protection  history.  In  the  cases  of  withdrawal,  a  patent
xamination  resulting  in  the  absence  of  patenting  criteria
or  a  technology  that  was  previously  experienced  abroad
ay  be  a  reason.  This  explanation  corresponds  with  the
bservation  that  most  of  the  documents  are  of  foreign  ori-
in  --  especially  being  from  the  USA  --  often  ﬁrst  applied
n  the  USA,  and  thus  able  to  retrieve  examination  results
ore  quickly.  Likewise,  some  patents  were  requested  almost
0  years  ago,  and  none  had  yet  been  deferred  yet  or  had
echnical  requirements,  conﬁrming  the  long-lasting  patent
xamination  process  in  Brazil,  although  efforts  are  being
ade  in  INPI  in  order  to  accelerate  this  process,  which  can
vercome  this  obstacle  and  result  in  a  very  different  sce-
ario  in  the  future.
onclusion
here  is  too  high  an  interest  among  multinational  compa-
ies  in  obtaining  patent  protection  for  their  biotechnological
roducts  in  Brazil,  especially  as  concerns  GM  plants.  This
nterest  is  likely  due  to  (1)  Brazil’s  status  as  an  agricul-
ural  power;  (2)  the  progressive  adhesion  to  GM  crops  in
he  last  decade;  (3)  the  role  of  GM  plants  in  supporting
he  development  of  agriculture;  and  (4)  the  capacity  of
M  plants  to  reduce  environmental  damage  by  diminishing
he  use  of  soil  and  decreasing  the  use  of  chemicals  such  as
nsecticides.
However,  national  companies  are  not  able  to  compete
ith  multinational  ones,  with  the  exception  of  EMBRAPA,
hich  was  6th  place  in  terms  of  patent  applications  for  agro-
iotechnologies.  Thus,  Brazil  is  not  yet  strongly  competitive
n  this  area,  particularly  compared  with  biotechnology-
eadership  countries  such  as  the  USA  and  China.
Additionally,  we  notice  that  broad  protection  is  the
ain  strategy  adopted  by  large  companies  in  the  develop-
ent  of  GM  plants.  This  strategy  comprises  the  protection
f  invented  genes/proteins  and  the  derivatives  of  these
nventions,  such  as  gene  constructs/cassettes,  production
ethods,  parts  of  GM  plants,  GM  plant-derived  products
nd  seed  mixtures.  Moreover,  many  companies  have  pro-
ected  agrobiotechnologies  comprising  stacked  genes  within
he  same  technology,  either  related  to  the  same  trait  (e.g.,
enes  for  insect  resistance)  or  to  distinct  traits  (e.g.,  genes
or  insect  resistance  and  genes  for  herbicide  tolerance).
n  the  case  of  Brazil,  despite  more  restrictive  laws,  broad
rotection  may  set  the  expectation  that  the  law  could  be
odiﬁed  when  documents  are  examined  in  the  future.
urrent status and perspectives
e  must  rethink  the  need  for  national  investment  in  projects
or  biotechnological  innovation  and  consolidate  already
xisting  initiatives,  such  as  the  National  Policies  for  Biotech-
ology  (Brasil,  2007),  the  legal  mark  of  science  technology
nd  innovation  (Law  N◦ 13.243/2016  and  Law  Decree  N◦
76  L.  Figueiredo  et  al.
Table  2  Brazilian  patent  requests  related  to  insect-resistant  GM  plants  (2010--2016).
Item  Patent  application
number
Event/Gene/Product/Process  Target  insects  Owner
1  BR112012014772  Vip3ab  and  Cry1fa  proteins  Lepidoptera  Dow
AgroSciences
2 BR112012015005  Cry1ca-modiﬁed  proteins  Lepidoptera  Dow
AgroSciences
3 BR112012014700  Cry1ab  and  Cry2aa  proteins Lepidoptera  Dow
AgroSciences
4 BR112012014727  Cry1da  and  Cry1be  proteins Lepidoptera  Dow
AgroSciences
5 BR112012014702  Protein  stackings:  Cry  1Fa-Cry2Aa  and  Cry  1l-Cry  1E  Lepidoptera  Dow
AgroSciences
6 BR112012014803  Vip3ab  and  Cry1ca  proteins  Lepidoptera  Dow
AgroSciences
7 BR112012014879  Cry1be  and  Cry1f  proteins  Lepidoptera  Dow
AgroSciences
8 BR112012014801  Cry1ca  and  Cry1fa  proteins  Lepidoptera  Dow
AgroSciences
9 BR112012014796  Cry1ab  and  Cry1be  proteins  Lepidoptera  Dow
AgroSciences
10 BR112012014681  Cry1da  and  Cry1ca  proteins  Lepidoptera  Dow
AgroSciences
11 BR102012019434  Insect-resistant  soybean  event  9582.814.19.1  (Cryl  F  and
CrylAc  (synpro)  proteins)  with  tolerance  to  herbicide
(PAT  protein)
Lepidoptera  Dow
AgroSciences
12 BR102012018662  Insect-resistant  soybean  event  pDAB9582.814.19.
1::pDAB4468.04.  16.1  (CrylF  and  CrylAc  (synpro)
proteins)  with  tolerance  to  herbicide  (AAD-12  and  PAT
proteins)
Lepidoptera  Dow
AgroSciences
13 BR102015025537  Gho/Sec24b2  and  Sec24b1  silencing  (RNAi)  Coleoptera
and/or
Hemiptera
Dow
AgroSciences
14 BR102013032916  Reptin  silencing  (RNAi) Coleoptera  Dow
AgroSciences
15 BR102012025724  pp1-87b  silencing  (RNAi)  Coleoptera  Dow
AgroSciences
16 PI1011950  Cry  and  Dig-11  proteins  Coleoptera  Dow
AgroSciences
17 PI1015333  Dig-3  proteins  Lepidoptera  Dow
AgroSciences
18 BR102012025759  rpa70  silencing  (RNAi)  Coleoptera  Dow
AgroSciences
19 BR102014031844  Opposite  Ras  silencing  (RNAi)  Coleoptera
and/or
Hemiptera
Dow
AgroSciences
20 BR102012025657  rps6  silencing  (RNAi)  Coleoptera  Dow
AgroSciences
21 BR112012014746  Cry1ca  and  Cry1ab  proteins  Lepidoptera  Dow
AgroSciences
22 BR112012027140  Cry34ab/35ab  and  Cry3ba  proteins  Coleoptera  Dow
AgroSciences
23 BR112012027139  Cry34ab/35ab  and  Cry6aa  proteins  Coleoptera  DowAgroSciences
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Table  2  (Continued)
Item  Patent  application
number
Event/Gene/Product/Process  Target  insects  Owner
24  BR112012027218  Cry34ab/35ab  and  Cry3aa  proteins  Coleoptera  Dow
AgroSciences
25 BR112012027208  Cry3aa  and  Cry6aa  proteins  Coleoptera  Dow
AgroSciences
26 BR112012014804  Cry1fa  and  Cry1ab  proteins Lepidoptera  Dow
AgroSciences
27 BR112012014665  Insect-resistant  maize  event  dp-004114-3  (Cry1F,
CRy34Ab1  and  Cry35Ab1  proteins)  with  tolerance  to
herbicide  (PAT  protein)
Coleoptera  DuPont
Pionner
28 PI0919339  Bt  toxins  Lepidoptera  DuPont
Pioneer
29 PI1007260  Bt  toxins Lepidoptera  DuPont
Pioneer
30 PI0918766  Bt  toxins Coleoptera  DuPont
Pioneer
31 PI0924154  Bt  toxins  Lepidoptera  DuPont
Pioneer
32 PI0924153  Bt  toxins  Lepidoptera  DuPont
Pioneer
33 PI0919336  Bt  toxins  Lepidoptera  DuPont
Pioneer
34 BR112012030913  Nezara  viridula  genes  silencing  (RNAi)  Hemiptera  DuPont
Pioneer
35 PI0823184  Cyt1,  Cry4A,  Cry4B,  Cry10,  Cry11,  Cyt2  and  Cry3
proteins
Coleoptera
and/or
Lepidoptera
EMBRAPA
36 PI1102841  Alpha-amylase  inhibitor  mutants  Coleoptera  EMBRAPA
37 PI0906128  Cry8Ha  protein  Coleoptera  EMBRAPA
38 BR102012033506  Laccase  family  genes  silencing  Coleoptera  EMBRAPA
39 BR102012033542  Cry1Ia12  protein  Lepidoptera  EMBRAPA
40 BR102013031014  Control  strategy  against  Athetis  lepigone  based  on  Cry1A
protein
Lepidoptera  Dabei  Nong
41 BR102013031821  Control  strategy  against  Lepidoptera  Dabei  Nong
Conogethes  punctiferalis  based  on  Cry1F  protein
42 BR102014003618  Control  strategy  against  Sesamia  inferens  based  on
Cry1B  protein
Lepidoptera  Dabei  Nong
43 BR102013031822  Control  strategy  against  Sesamia  inferens  based  on
Cry1F  protein
Lepidoptera  Dabei  Nong
44 BR102013031734  Control  strategy  against  Athetis  lepigone  based  on  Cry1F
protein
Lepidoptera  Dabei  Nong
45 BR102013018436  PIC9-modiﬁed  protein  Lepidoptera  Dabei  Nong
46 BR102013018337  PIC9-modiﬁed  protein  Lepidoptera  Dabei  Nong
47 BR112013000262  Insect-resistant  maize  events  MIR604,  BT11  and  MIR162
(Cry3A,  Cry1Ab  and  Vip3Aa20  proteins)
Coleoptera  Syngenta
48 PI0922656  Insect-resistant  maize  event  5307  (FR8  protein  and  PMI
gene marker)
Coleoptera  Syngenta
p9.283/2018)  (Brasil,  2016,  2018b)  and  EMBRAPII  (Brasil,
2013),  which  aim  to  expand  partnerships  with  companies
and  encourage  biotechnological  development  by  national
companies  and  institutes.  These  efforts  will  certainly  boost
innovation  and  increase  the  number  of  biotechnological
s
s
aroducts  in  the  market  and  that  of  patent  applications,  con-
equently  strengthening  the  Brazilian  economy.
Although  examining  patent  applications  in  Brazil  is  a  very
low  process  --  which  affected  our  analyses  --  INPI  has  cre-
ted  strategies  to  accelerate  it,  stimulating  applicants  to
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pply  for  patents  in  Brazil.  Some  of  these  strategies  include
riority  for  applications  involving  green  patents  (INPI,
016a),  which  comprise  technologies  for  the  environment
uch  as  alternative  energy  sources,  energy  conservation,  the
anagement  of  residues  and  sustainable  agriculture.
The  INPI  considers  sustainable  agriculture  to  be  as  fol-
ows:  (1)  reforestation  techniques;  (2)  alternative  watering
echniques;  (3)  alternative  pesticides  and  (4)  soil  improve-
ent  (e.g.,  residue-derived  organic  fertilizers).  GM  plants
re  not  included  in  this  panel,  despite  the  potential  envi-
onmental  beneﬁts  mentioned  above;  this  is  an  important
opic  that  should  be  taken  into  account  by  INPI  when  consid-
ring  priority  application.  In  parallel,  the  pilot  projects  for
riority  application  of  requested  patents  from  institutes  of
cience  and  technology  (IST  Patents)  (INPI,  2017a),  micro-
nd  small-sized  enterprises  (MSE  Patents)  (INPI,  2016b;
017b)  and  of  Brazilian  origin,  with  priority  rights  assured
or  application  in  different  national  or  international  patent
fﬁces  (BR  Priority)  (INPI,  2015b;  2017c),  have  been  ini-
iatives  undertaken  by  INPI  to  accelerate  the  examination
rocess.
The  protection  strategies  involving  gene  pyramiding  are
nother  alternative  for  use  by  Brazilian  companies  and  insti-
utions.  Moreover,  knowing  the  existing  technologies  may
acilitate  the  development  of  new  technologies  and  expand
pportunities  for  partnerships  with  owners.  Finally,  to  bet-
er  promote  the  independence  of  national  companies  in  this
ector,  using  technologies  within  the  public  domain  is  also  an
lternative,  provided  that  there  is  the  constant  monitoring
f  activity  in  corresponding  patent  databases.
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